Vaxart
VXRT
$0.73
Share price
-2.68%
Change (1 day)
-16.22%
Change (1 year)
Categories
Vaxart (VXRT) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $34.02 M
According to Vaxart's latest financial reports the company's total liabilities are $34.02 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Vaxart - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $34.02 M | -21.33% |
| 2022-12-31 | $43.25 M | 28.58% |
| 2021-12-31 | $33.63 M | 15.28% |
| 2020-12-31 | $29.17 M | 21.17% |
| 2019-12-31 | $24.08 M | 0.38% |
| 2018-12-31 | $23.98 M | |
| 2017-06-30 | $21.4 M | -19.25% |
| 2016-06-30 | $26.5 M | 167.68% |
| 2015-06-30 | $9.9 M | -63.47% |
| 2014-06-30 | $27.1 M | 52.25% |
| 2013-06-30 | $17.8 M | |
| 2011-12-31 | $39.09 M | -26.65% |
| 2010-12-31 | $53.3 M | 57.18% |
| 2009-12-31 | $33.91 M | 48.47% |
| 2008-12-31 | $22.83 M | -75.19% |
| 2007-12-31 | $92.03 M | -40.42% |
| 2006-12-31 | $0.15 B | -7.77% |
| 2005-12-31 | $0.16 B | 99.77% |
| 2004-12-31 | $83.85 M | 23.34% |
| 2003-12-31 | $67.98 M | 55.26% |
| 2002-12-31 | $43.78 M | -64.43% |
| 2001-12-31 | $0.12 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $3.14 M | -90.75% | Bahamas |
 NRC Health
NRC | $73.48 M | 115.96% | 🇺🇸 USA |